WuXi Healthcare Ventures closes a $290M fund to invest in U.S. and China life sciences startups
The cross-border investment firm now has $350 million under management. It's invested in some high profile biopharma companies - including Juno Therapeutics, Foundation Medicine and Novira Therapeutics.